Randomized Study Of Exercise And Vitamin D In Frail Elderly Subjects
NCT00249704 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2009-01-08
Summary
The study will explore multiple mobility function tests as well as functional and neuropsychological tests in elderly subjects at risk for falls and disability, before and after 4-month exercise and/or Vitamin D intervention.
Conditions
- Elderly, Frail
Interventions
- DRUG
-
Vitamin D + Sham Exercise
1000 IU per day of Vitamin D + Sham (equivalent to placebo) Exercise
- PROCEDURE
-
Vitamin D Placebo + Exercise
Vitamin D placebo + Exercise
- PROCEDURE
-
Vitamin D Placebo + Sham Exercise
Vitamin D placebo + Sham (equivalent to placebo) Exercise
- DRUG
-
Vitamin D + Exercise
1000 IU per day of Vitamin D + Exercise
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-31
- Completion
- 2008-01-31
Countries
- United States
Study Locations
More Related Trials
-
A First in Human Study of RT001 in Patients With Friedreich's Ataxia
NCT02445794 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia
NCT05573698 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
NCT01605825 ·Status: COMPLETED ·Phase: PHASE2
-
Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation
NCT01386944 ·Status: COMPLETED
-
Treadmill Training in Fragile X-associated Tremor/Ataxia Syndrome
NCT04428567 ·Status: TERMINATED ·Phase: NA
-
Indomethacin and Mechanisms Underlying Risk of Falling
NCT00462111 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effect of Dextro-Amphetamin Added to Physiotherapy in Patients After Stroke
NCT00572767 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Trial for Asses the Safety and Efficacy of Vitamin C and Vitamin E in Combination Versus Placebo for Treating Cognitive and Behavior Disorder in Children With Fragile X Syndrome
NCT02942498 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)
NCT00647296 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
NCT04577352 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans
NCT03754842 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
NCT02422940 ·Status: TERMINATED ·Phase: PHASE3
-
Technical Development of Clinical Laboratory Studies
NCT03253718 ·Status: WITHDRAWN
-
A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)
NCT00152958 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.
NCT02271217 ·Status: COMPLETED ·Phase: PHASE3
-
Observe Change in Nasal Swab DRD2 Gene Expression in Restless Legs Syndrome (RLS) Patients on Prolonged Dopamine Agonist Treatment
NCT06726785 ·Status: RECRUITING
-
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
NCT01083667 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
NCT01898884 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia
NCT04102501 ·Status: COMPLETED ·Phase: PHASE3
-
A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia
NCT06874010 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients
NCT02146534 ·Status: COMPLETED ·Phase: PHASE4
-
Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
NCT00584948 ·Status: COMPLETED ·Phase: NA
-
Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease
NCT04094948 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy
NCT00374075 ·Status: COMPLETED ·Phase: PHASE1
-
Dexpramipexole SAD/MAD Study
NCT01449578 ·Status: COMPLETED ·Phase: PHASE1